RE:RE:RE:RE:SBFM up 150% on mRNA oncology news The problem we have as Th shareholders is that when disturbing events like this one occurs out of the blue it should be viewed as an opportunity by some market players like Soleus. Because of their communication and self esteem problems we are sitting ducks between now and some game changer events. They actually beleive Thera is a 3$ company since they were willing to do a financing at that price. Now I'm shure they will confirm that view once again with a similar deal because of the market conditions of course. I'm voting not to send a message but for a change this year. I hope many shareholders decide like me to take the future of their investment in hand and actually do something about it. If it does'nt work out for change you gain the right to complain. If you don't vote you don't get to complain, you accept the statu quo. Now what are the alternatives, that is an interesting debate to start.